292 related articles for article (PubMed ID: 25567841)
1. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.
Troy SB; Kouiavskaia D; Siik J; Kochba E; Beydoun H; Mirochnitchenko O; Levin Y; Khardori N; Chumakov K; Maldonado Y
J Infect Dis; 2015 Jun; 211(12):1969-76. PubMed ID: 25567841
[TBL] [Abstract][Full Text] [Related]
2. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.
Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595
[TBL] [Abstract][Full Text] [Related]
3. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.
Snider CJ; Zaman K; Estivariz CF; Yunus M; Weldon WC; Wannemuehler KA; Oberste MS; Pallansch MA; Wassilak SG; Bari TIA; Anand A
Lancet; 2019 Jun; 393(10191):2624-2634. PubMed ID: 31104832
[TBL] [Abstract][Full Text] [Related]
5. Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.
Kouiavskaia D; Mirochnitchenko O; Dragunsky E; Kochba E; Levin Y; Troy S; Chumakov K
J Infect Dis; 2015 May; 211(9):1447-50. PubMed ID: 25391313
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
Anand A; Molodecky NA; Pallansch MA; Sutter RW
Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.
Cadorna-Carlos J; Vidor E; Bonnet MC
Int J Infect Dis; 2012 Feb; 16(2):e110-6. PubMed ID: 22153001
[TBL] [Abstract][Full Text] [Related]
8. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
[TBL] [Abstract][Full Text] [Related]
9. Intradermal fractional dose inactivated polio vaccine: a review of the literature.
Nelson KS; Janssen JM; Troy SB; Maldonado Y
Vaccine; 2012 Jan; 30(2):121-5. PubMed ID: 22100886
[TBL] [Abstract][Full Text] [Related]
10. Fractional doses of inactivated poliovirus vaccine in Oman.
Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.
Bandyopadhyay AS; Gast C; Rivera L; Sáez-Llorens X; Oberste MS; Weldon WC; Modlin J; Clemens R; Costa Clemens SA; Jimeno J; Rüttimann R
Lancet Infect Dis; 2021 Apr; 21(4):559-568. PubMed ID: 33284114
[TBL] [Abstract][Full Text] [Related]
12. Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.
Resik S; Tejeda A; Diaz M; Okayasu H; Sein C; Molodecky NA; Fonseca M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter RW
J Infect Dis; 2017 Jan; 215(2):175-182. PubMed ID: 28073858
[TBL] [Abstract][Full Text] [Related]
13. Priming after a fractional dose of inactivated poliovirus vaccine.
Resik S; Tejeda A; Sutter RW; Diaz M; Sarmiento L; Alemañi N; Garcia G; Fonseca M; Hung LH; Kahn AL; Burton A; Landaverde JM; Aylward RB
N Engl J Med; 2013 Jan; 368(5):416-24. PubMed ID: 23363495
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.
Resik S; Tejeda A; Lago PM; Diaz M; Carmenates A; Sarmiento L; Alemañi N; Galindo B; Burton A; Friede M; Landaverde M; Sutter RW
J Infect Dis; 2010 May; 201(9):1344-52. PubMed ID: 20350164
[TBL] [Abstract][Full Text] [Related]
15. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial.
Anand A; Zaman K; Estívariz CF; Yunus M; Gary HE; Weldon WC; Bari TI; Steven Oberste M; Wassilak SG; Luby SP; Heffelfinger JD; Pallansch MA
Vaccine; 2015 Nov; 33(48):6816-22. PubMed ID: 26476367
[TBL] [Abstract][Full Text] [Related]
16. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
[TBL] [Abstract][Full Text] [Related]
17. Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
Wang Y; Zade J; Moon SS; Weldon W; Pisal SS; Glass RI; Dhere RM; Jiang B
Vaccine; 2019 Jan; 37(5):698-704. PubMed ID: 30626530
[TBL] [Abstract][Full Text] [Related]
18. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
[TBL] [Abstract][Full Text] [Related]
20. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]